Volume: 11, Issue: 2
ABSTRACT
Alzheimer's disease (AD), the most prevalent kind of dementia, mostly affects the elderly and poses serious problems to worldwide health systems. Several possible therapies exist, but no drug available today can restore or replace destroyed neurons. Researchers are developing novel medicines and treatments for AD. The likelihood of having AD grows with older age. AD has a profound effect on memory, thinking, and behavior. Few new medications showed promise, and most trials concluded that they were either unsafe or did not significantly assist. Although the existing FDA-approved therapies, such as acetylcholinesterase inhibitors and memantine, effectively control symptoms, they do not stop the advancement of the disease. Innovative treatment approaches such as gene therapy, immunotherapy, theragnostic, and metal-based chelators provide renewed optimism. Although significant progress has been made, the ongoing growth of the aging population necessitates the implementation of cutting-edge research and clinical trials to address the rising incidence of Alzheimer's disease (AD) and its impact on society.
Geriatric Healthcare, Alzheimer’s Disease, clinical trials